Gilead Sciences Q4 FY25: where the revenue came from and where it went
The whole income statement of Gilead Sciences for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Oct 1 – Dec 31, 2025
- Reported
- Feb 24, 2026
Revenue$7.9B
+5% year over year
Gross profit$6.3B
80% margin
Operating profit$2.0B
25% margin
Net profit$2.2B
28% margin
Net profit is larger than what operations earned, because the statement adds $0.2B below it, under Tax benefit and other.
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 7.9 | 100% | +5% |
| Cost of revenue | −1.6 | 20% | |
| Gross profit | 6.3 | 80% margin | +0pp |
| SG&A | −1.8 | 22% | −3pp |
| Other | −2.5 | 32% | +0pp |
| Operating profit | 2.0 | 25% margin | −7pp |
| Tax benefit and other | 0.2 | ||
| Net profit | 2.2 | 28% margin | +4pp |
347 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest